Heart Protection With SGLT2, GLP-1 Drugs for Diabetes Mediated by Age

(MedPage Today) — The age of type 2 diabetes patients may alter the level of cardioprotection from two newer classes of anti-diabetic agents, a network meta-analysis suggested.
The relative reduction in major adverse cardiovascular events (MACE…

Source link : https://www.medpagetoday.com/endocrinology/diabetes/114051

Author :

Publish date : 2025-02-03 18:31:02

Copyright for syndicated content belongs to the linked Source.